DISQUS

VentureBeat: Genentech takes a step back from the dark side, delays Avastin restrictions

  • David E. Williams of the Healt · 2 years ago
    Stay tuned, as I am planning to get to the bottom of this one.

    I'm also a little more optimistic than you are about getting the FDA to comment. I've posted an email the FDA sent the American Academy of Ophthalmology, and have followed up with the FDA in the hopes of getting more information.
  • David P. Hamilton · 2 years ago
    Thanks, David. I noted your subsequent item at the end of this roundup. We'll keep an eye on this.